CABG Preferable to PCI for Multivessel Disease in Diabetics: Canadian Registry (Dr. Krishnan Ramanathan)
Diabetic patients undergoing revascularization for multivessel coronary disease have a lower risk of death, heart attack, and serious complications if they receive CABG instead of PCI, especially if the setting is stabilized acute coronary syndrome, suggests Canadian registry data presented this week here at the American Heart Association (AHA) 2015 Scientific Sessions.
“Our data suggest that some people undergoing PCI may be better with bypass surgery. However, we need a proper randomized controlled trial to answer this question,” commented lead author Dr Krishnan Ramanathan (University of British Columbia, Vancouver).
The results provide real-world confirmation of findings from theFREEDOM trial, which showed superiority of bypass surgery over PCI with drug-eluting stents (DES) in diabetics with multivessel disease.
Veronica Hackethal reports.
Dianne Doyle, President & CEO, and Geoff Plant, Chair, PHC Board of Directors